Data as of Oct 30
| -0.05 / -0.33%|
The 13 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 20.67, with a high estimate of 22.89 and a low estimate of 13.58. The median estimate represents a +37.05% increase from the last price of 15.08.
The current consensus among 14 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.